Functionality of Endogenous Biological Clock in Sepsis
NCT04063332 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-12-12
Summary
The aim of the current study is to demonstrate dysregulation of immune system΄s circadian rhythms as a consequence of sepsis, as well as marked malfunction of the central circadian clock in comparison with patients without sepsis , the presence of which burdens independently the final outcome and , hence, need to be addressed.
Conditions
- Circadian Rhythm Disorders
- Sepsis
Sponsors & Collaborators
-
Hellenic Sepsis Study Group
collaborator OTHER -
University of Athens
lead OTHER
Principal Investigators
-
Evangelos J Giamarellos-Bourboulis, MD, PhD · University of Athens
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-06-03
- Primary Completion
- 2024-06-30
- Completion
- 2024-06-30
Countries
- Greece
Study Locations
More Related Trials
-
Cerebrovascular Autoregulation During Sepsis
NCT01029080 ·Status: COMPLETED
-
Diagnostic Accuracy in Sepsis
NCT03956043 ·Status: COMPLETED
-
Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
NCT03345992 ·Status: COMPLETED ·Phase: PHASE3
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
An Acupuncture Study for People At High Risk for Sepsis
NCT06344819 ·Status: RECRUITING ·Phase: PHASE2
-
Zinc and Inflammation in Sepsis
NCT01328509 ·Status: COMPLETED
-
Assessing Immune Dysfunction in Sepsis
NCT07154615 ·Status: RECRUITING
-
Value of Laboratory Biomarkers in Prediction of Outcome in Septic Patients
NCT06338124 ·Status: RECRUITING
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis
NCT03333304 ·Status: COMPLETED ·Phase: NA
-
NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification
NCT06141395 ·Status: COMPLETED
-
Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.
NCT01450358 ·Status: COMPLETED ·Phase: PHASE4
-
Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast Thailand
NCT02217592 ·Status: COMPLETED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis
NCT04199962 ·Status: UNKNOWN
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
Clarithromycin as Immunomodulator for the Management of Sepsis
NCT01223690 ·Status: COMPLETED ·Phase: PHASE3
-
Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients
NCT02883218 ·Status: COMPLETED
-
Efficacy and Safety of Electroacupuncture for ICU Sepsis Patients
NCT06666946 ·Status: RECRUITING ·Phase: NA
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382 ·Status: WITHDRAWN
-
Mitochondrial Function of Immune Cells in Sepsis
NCT01600989 ·Status: COMPLETED
-
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684 ·Status: RECRUITING